SC 13G 1 0001.txt SPEECHWORKS INTERNATIONAL SC 13G United States Securities and Exchange Commission WASHINGTON, D.C. 20549 Schedule 13G (Amendment ___*) UNDER THE SECURITIES EXCHANGE ACT OF 1934 RITA Medical System, Inc. -------------------------------------------------------- (Name of Issuer) Common Stock --------------------------------------------------- (Title of Class of Securities) 76774 E --------------------------------------------------- (CUSIP Number) December 31, 2000 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-1(c) |X| Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 76774 E Page 2 of 7 Pages ------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Bank of America Ventures 95-6016836 ------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group (a) (b) X ------------------------------------------------------------------------------- (3) SEC Use Only ------------------------------------------------------------------------------- (4) Citizenship or Place of Organization California, United States of America ------------------------------------------------------------------------------- Number Of Shares (5) Sole Voting Power 741,818 Beneficially Owned By Each Reporting (6) Shared Voting Power -0- Person With (7) Sole Dispositive Power 741,818 (8) Shared Dispositive Power -0- (9) Aggregate Amount Beneficially Owned By Each Reporting Person 741,818 ------------------------------------------------------------------------------- (10) Check If The Aggregate Amount In Row (11) Excludes Certain Shares* ------------------------------------------------------------------------------- (11) Percent Of Class Represented By Amount In Row (11) 5.3% ------------------------------------------------------------------------------- (12) Type Of Reporting Person PN ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 7 Pages CUSIP No. 76774 E Page 3 of 7 Pages (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons BA Venture Partners IV 94-3353328 ------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group (a) (b) X ------------------------------------------------------------------------------- (3) SEC Use Only ------------------------------------------------------------------------------- (4) Citizenship or Place of Organization California, United States of America ------------------------------------------------------------------------------- Number Of Shares (5) Sole Voting Power 130,909 Beneficially Owned By Each Reporting (6) Shared Voting Power -0- Person With (7) Sole Dispositive Power 130,909 (8) Shared Dispositive Power -0- (9) Aggregate Amount Beneficially Owned By Each Reporting Person 130,909 ------------------------------------------------------------------------------- (10) Check If The Aggregate Amount In Row (11) Excludes Certain Shares* ------------------------------------------------------------------------------- (11) Percent Of Class Represented By Amount In Row (11) 0.93% ------------------------------------------------------------------------------- (12) Type Of Reporting Person PN ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 3 of 7 Pages Page 4 of 7 pages Item 1. (a) Name of Issuer: RITA Medical Systems, Inc. ("Issuer") (b) Address of Issuer's Principal Executive Offices: 967 North Shoreline Boulevard Mountain View, CA 94013 Item 2. (a) Name of Person Filing: Bank of America Ventures ("BA Ventures") BA Venture Partners IV ("BA IV") (b) Address of Principal Business Office: Bank America Ventures 950 Tower Lane, Suite 700 Foster City, CA 94404 (c) Citizenship/Place of Organization: BA Ventures - California BA IV - California (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 76774 E Item 3. Not applicable. Page 4 of 7 pages Page 5 of 7 Pages Item 4 Ownership.
------- ---------------------- ---------------------------------- ------------------ BA Ventures BA IV ------- ---------------------- ---------------------------------- ------------------ (a) Beneficial Ownership 741,818 130,909 ------- ---------------------- ---------------------------------- ------------------ (b) Percentage of Class 5.3% 0.93% ------- ---------------------- ---------------------------------- ------------------ (c) Sole Voting Power 741,818 130,909 ------- ---------------------- ---------------------------------- ------------------ Shared Voting Power -0- -0- ------- ---------------------- ---------------------------------- ------------------ Sole Dispositive 741,818 130,909 Power ------- ---------------------- ---------------------------------- ------------------ Shared Dispositive -0- -0- Power ------- ---------------------- ---------------------------------- ------------------
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of class of securities, check the following: Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group No reporting person is a member of a group as defined in Section 240.13d-1(b)(1)(ii)(H) of the Act. Item 9. Notice of Dissolution of Group Not applicable. EXHIBIT(S): A. Joint Filing Statement Page 5 of 7 Pages Page 6 of 7 Pages Item 10. Certification After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 8, 2001 BANK OF AMERICA VENTURES By: /s/ Mark Brooks ----------------------------------------- Principal BA VENTURE PARTNERS IV By: /s/ Mark Brooks ----------------------------------------- General Partner Page 6 of 7 pages Page 7 of 7 Pages EXHIBIT A We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of us. Date: February 8, 2001 BANK OF AMERICA VENTURES By: /s/ Mark Brooks ----------------------------------------- Principal BA VENTURE PARTNERS IV By: /s/ Mark Brooks ----------------------------------------- General Partner Page 7 of 7 Pages